1-(3-Aminobenzenesulfonyl)piperidin-4-ol, 95%, 250mg

4-Bromo-3-fluoro-2-methoxy-benzaldehyde, 95%, 250mg

2-(2-Pyridyl)ethanesulfonic acid, 95.0%, 5g

7-Methyl-1h-pyrrolo[3,2-b]pyridine-3-carboxylic acid, 98+%, 1g

7-chloro-3-(2-methoxy-5-methylphenyl)-2-sulfanylidene-1,2,3,4-tetrahydroquinazolin-4-one, 98%, 250mg

(S)-4-(1,3-Dioxoisoindolin-2-yl)-2-hydroxybutanoic acid, 95.0%, 50g

4-Bromo-8-methoxyquinoline, 95.0%, 5g

2-NITRO-5-TRIFLUOROMETHYLBENZOIC ACID, 95.0%, 5g

Moexipril hydrochloride, 98%, 25mg

TERT-BUTYL (2S,4R)-4-FLUORO-2-FORMYLPYRROLIDINE-1-CARBOXYLATE, 95%, 5g

Recipiente di reazione a flangia piatta cilindrico, graduato (1) Fondo tondo, DN 150, 160 mm, Altezza, 390 mm, 1 Pezzo

4-(1-piperidinylmethyl)benzoic acid hydrate, 95.0%, 1g

N-(5-Chloro-2-hydroxyphenyl)acetamide, 95.0%, 5g